2.54
+0.04
(1.60%)
May 21 - Close
NASDAQ
real-time data -
Disclaimer
Currency in USD
| Range | 2.41 - 2.54 |
| 52 week | 1.06 - 3.25 |
| Open | 2.49 |
| Vol / Avg. | 255,610.00/324,532.00 |
| Mkt cap | 142.67M |
| P/E | - |
| Div/yield | - |
| EPS | -1.56 |
| Shares | 56.17M |
| Beta | - |
| Inst. own | 64% |
Events
Apr 29, 2013
Q1 2013 Pacific Biosciences Of California Inc Earnings Release
Apr 23, 2013
Q1 2013 Pacific Biosciences Of California Inc Earnings Conference Call
Feb 25, 2013
Pacific Biosciences Of California Inc at Citi Global Healthcare Conference
|
More events from DailyFinance »
|
Key stats and ratios
| Q1 (Mar '13) | 2012 | |
| Net profit margin | -378.34% | -363.56% |
| Operating margin | -369.43% | -363.08% |
| EBITD margin | - | -337.49% |
| Return on average assets | -62.83% | -54.29% |
| Return on average equity | -78.21% | -62.80% |
| Employees | 342 | - |
| Carbon Disclosure Rating | - | - |
Address
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
Pacific Biosciences, Inc. develops Deoxyribonucleic Acid (DNA) sequencing platform. The Company designs and develops a method for single-molecule DNA sequencing that was developed through collaboration between the research groups of Harold Craighead and Watt Webb at Cornell University, United States. The Company's single molecule real time (SMRT) technology's combination of performance characteristics is the result of an approach that uses a single DNA polymerase working in a continuous processing manner to synthesize DNA.
Officers and directors
| Michael W. Hunkapiller Ph.D. | Executive Chairman of the Board, President, Chief Executive Officer | |
| Susan K. Barnes | Chief Financial Officer, Executive Vice President | |
| Kevin Corcoran | Senior Vice President | |
| Michael Phillips | Senior Vice President - Research and Development | |
| Jonas Korlach Ph.D. | Chief Scientific Officer | |
| William Ericson | Lead Independent Director | |
| David Botstein Ph.D. | Director | |
| Anthony B. Evnin Ph.D. | Director | |
| Lucy Shapiro Ph.D. | Director | |
| Brook H. Byers | Independent Director |